David Papin

Title: Innovator Spotlight: David Papin and His Contributions to Medical Science

Introduction: David Papin, a notable inventor based in Paris, France, has made significant strides in the field of medical science. With a focus on peptide complexes and their applications, Papin is making a name for himself in the biotechnology sector, particularly through his work with the global pharmaceutical company Sanofi.

Latest Patents: Papin holds one patent titled "Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the same." This innovation relates to a peptide or peptide complex that binds to the α2 integrin. The patent includes several components, such as one or more nucleic acids coding for the peptide, a recombinant cell capable of producing the peptide or complex, and methods for producing it. Moreover, it also describes a pharmaceutical composition utilizing the peptide or nucleic acids for therapeutic purposes, methods for detecting α2 integrin, and a screening method.

Career Highlights: Throughout his career, David Papin has been dedicated to advancing medical knowledge and improving treatment options. His work at Sanofi has put him at the forefront of pharmaceutical research, where he leverages cutting-edge technology to develop new therapeutic solutions that can benefit patients worldwide.

Collaborations: David has collaborated with notable colleagues such as Carsten Corvey and Horst Blum. Their combined expertise and shared vision in peptide research have contributed to the advancements in their field and have fostered an environment of innovation and discovery.

Conclusion: As an inventor, David Papin showcases how dedication to research and innovation can lead to significant medical advancements. His patent on peptides binding to α2 integrin reflects a critical step toward developing effective treatments. As he continues his work at Sanofi, the potential for his contributions to medical science remains promising, paving the way for future discoveries.